Shawn Levy

Biography
Shawn has over 20 years of experience in genomic applications development and technology optimization, as well as operational management of research, development, and clinical testing programs. Prior to joining Element, Shawn was Chief Scientific Officer at Discovery Life Sciences and a faculty investigator at the HudsonAlpha Institute for Biotechnology. While at HudsonAlpha, Shawn developed a comprehensive genomics facility that has supported more than 5,200 projects from locations around the world. His laboratory raised more than $150M in extramural funding, culminating in the largest financial transaction in HudsonAlphas history when the assets of his research group were sold to Discovery Life Sciences. Before HudsonAlpha, Shawn was a faculty member at Vanderbilt University Medical Center in the Department of Biomedical Informatics and the Department of Molecular Physiology and Biophysics. He is an author or coauthor of more than 200 peerreviewed publications with over 45,000 citations.

---

Talk

Sequencing Technologies Showcase:
Element Biosciences
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. For our first product AVITI is a modular and high-performing DNA sequencing platform that will deliver high-quality data, workflow flexibility and make next-generation sequencing technology more accessible.

Democratizing and decentralizing DNA sequencing with the Element
The AVITI system flips the script by providing higher quality data at a much lower cost.